DoseSpot is a healthcare innovator empowering clinicians with ePrescription software, founded in 2009 and based in Dedham, MA. The company's solution, which is Surescripts certified, simplifies the prescription lifecycle by integrating with EHRs, allowing clinicians to electronically write and transmit prescriptions to pharmacies without leaving their core workflows. DoseSpot serves more than 300 healthcare clients across various sectors including digital/telehealth firms, hospice pharmacies, EHR and practice management software companies, and dental services. With a focus on openness to new ideas, creative collaboration, and innovative technology, DoseSpot has completed over 300 successful integrations and provides API and technical expertise to get medical, dental, telehealth, and digital health companies up and running with ePrescribing swiftly. The company recently received a Private Equity Round investment from PSG Equity on 26 January 2022. DoseSpot's dedication to streamlining the ePrescribing process and commitment to embracing new technologies make it an intriguing prospect for venture capitalists looking to invest in the healthcare and information technology industries. More information about their services can be found at www.dosespot.com.
No recent news or press coverage available for DoseSpot.